Abstract:We report here the presence of numerous processed pseudogenes derived from the W family of endogenous retroviruses in the human genome. These pseudogenes are structurally colinear with the retroviral mRNA followed by a poly(A) tail. Our analysis of insertion sites of HERV-W processed pseudogenes shows a strong preference for the insertion motif of long interspersed nuclear element (LINE) retrotransposons. The genomic distribution, stability during evolution, and frequent truncations at the 5Ј end resemble thos… Show more
“…We generated three reporter constructs, derived from L1.3, for which the first 10 bp immediately upstream of the L1 start were replaced by the corresponding sequences present in L1C, The underlined sequence at the top is the previously reported HERV-W LTR consensus sequence, also termed LTR17. Previously reported HERV-W full-length pseudogenes (Costas 2002;Pavlicek et al 2002a) are exemplified. GenBank accession nos.…”
Section: Impact Of Genomic 5ј-flanking Sequences On L1 Transcriptionmentioning
Human L1 elements are non-LTR retrotransposons that comprise ∼17% of the human genome. Their 5Ј-untranslated region (5Ј-UTR) serves as a promoter for L1 transcription. Now we find that transcription initiation sites are not restricted to nucleotide +1 but vary considerably in both downstream and upstream directions. Transcription initiating upstream explains additional nucleotides often seen between the 5Ј-target site duplication and the L1 start site. A higher frequency of G nucleotides observed upstream from the L1 can be explained by reverse transcription of the L1 RNA 5Ј-CAP, which is further supported by extra Gs seen for full-length HERV-W pseudogenes. We assayed 5Ј-UTR promoter activities for several full-length human L1 elements, and found that upstream flanking cellular sequences strongly influence the L1 5Ј-UTR promoter. These sequences either repress or enhance the L1 promoter activity. Therefore, the evolutionary success of a human L1 in producing progeny depends not only on the L1 itself, but also on its genomic integration site. The promoter mechanism of L1 is reminiscent of initiator (Inr) elements that are TATA-less promoters expressing several cellular genes. We suggest that the L1 5Ј-UTR is able to form an Inr element that reaches into upstream flanking sequence.
“…We generated three reporter constructs, derived from L1.3, for which the first 10 bp immediately upstream of the L1 start were replaced by the corresponding sequences present in L1C, The underlined sequence at the top is the previously reported HERV-W LTR consensus sequence, also termed LTR17. Previously reported HERV-W full-length pseudogenes (Costas 2002;Pavlicek et al 2002a) are exemplified. GenBank accession nos.…”
Section: Impact Of Genomic 5ј-flanking Sequences On L1 Transcriptionmentioning
Human L1 elements are non-LTR retrotransposons that comprise ∼17% of the human genome. Their 5Ј-untranslated region (5Ј-UTR) serves as a promoter for L1 transcription. Now we find that transcription initiation sites are not restricted to nucleotide +1 but vary considerably in both downstream and upstream directions. Transcription initiating upstream explains additional nucleotides often seen between the 5Ј-target site duplication and the L1 start site. A higher frequency of G nucleotides observed upstream from the L1 can be explained by reverse transcription of the L1 RNA 5Ј-CAP, which is further supported by extra Gs seen for full-length HERV-W pseudogenes. We assayed 5Ј-UTR promoter activities for several full-length human L1 elements, and found that upstream flanking cellular sequences strongly influence the L1 5Ј-UTR promoter. These sequences either repress or enhance the L1 promoter activity. Therefore, the evolutionary success of a human L1 in producing progeny depends not only on the L1 itself, but also on its genomic integration site. The promoter mechanism of L1 is reminiscent of initiator (Inr) elements that are TATA-less promoters expressing several cellular genes. We suggest that the L1 5Ј-UTR is able to form an Inr element that reaches into upstream flanking sequence.
“…Les événements de « capture » d'un gène env sont susceptibles de se produire par au moins trois mécanismes de recombinaison: après co-encapsidation de génomes rétroviraux hétéro-logues [40], par brassage intragénomique d'exons par les rétro-éléments [24,26] …”
Section: Discussionunclassified
“…Toutefois, les propriétés de la composante de surface SU permettent également d'envisager une parenté avec des gènes codant pour des ligands de récepteurs membranaires (immunoglobulines, cytokines…). Ces deux origines pourraient être conciliées dans le cadre de la formation d'Env par recombinaison stochastique de domaines distincts des protéines [22,23], tel que cela est décrit, par exemple, dans le mécanisme de brassage des exons [24][25][26]. La plus forte conservation, au sein des enveloppes rétrovirales, des séquences TM par rapport aux séquences SU, suggère une acquisition modulaire en deux temps, au moins [27].…”
“…Processed pseudogenes can be derived from alternatively spliced mRNAs (24,25,30), antisense transcripts (31), or mRNAs derived from other repetitive elements such as endogenous retroviruses (30,32,33). It seems that virtually any RNA including non-coding RNAs can be potentially retroposed by L1 elements.…”
Section: Processed Pseudogenesmentioning
confidence: 99%
“…Approximately 90% of HERV genomic elements are such solo LTRs (3). Full-length elements are mostly found in regions with low recombination rates, such as AT-rich regions or chromosome Y (3,30,90,92,93). Thus, the HERV distribution is strikingly different from the insertional pattern of exogenous retroviruses and mostly reflects post-insertional processes.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.